Different saliva substitutes for treatment of xerostomia following radiotherapy a prospective crossover study

Strahlentherapie und Onkologie

Volumn 181, Issue 4, 2005, Pages 231-236

  Momm, Felix ^a   Volegova Neher, Natalja Jurievna ^a   Schulte Mönting, Jürgen ^b   Guttenberger, Roland ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Head and neck cancer; Radiotherapy; Saliva substitutes; Supportive care; Xerostomia

Indexed keywords

ALDIAMED; ALOE VERA EXTRACT; CARBOXYMETHYLCELLULOSE; GLANDOSANE; MUCIN; RAPESEED OIL; SALIVA MEDAC; SALIVA SUBSTITUTE;

ADULT; AEROSOL; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GEL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RADIATION INJURY; STATISTICAL SIGNIFICANCE; XEROSTOMIA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHOICE BEHAVIOR; CROSS-OVER STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SALIVA, ARTIFICIAL; TREATMENT OUTCOME; XEROPHTHALMIA;

EID: 17844372724     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1333-7     Document Type: Article

References (37)

1. Allal AS, Dulguerov P, Bieri S, et al. Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas. Head Neck 2000;22:288-93.
2. Bieri S, Bentzen SM, Huguenin P, et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003;179: 390-5.
3. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
4. Davies AN, Singer J. A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. J Laryngol Otol 1994;108:663-5.
5. Dörr W, Riesenbeck D. Mundhöhle. In: Dörr W, Zimmermann JS, Seegenschmiedt MH, Hrsg. Nebenwirkungen in der Radioonkologie. München: Urban & Vogel, 2000:130-42.
6. Emami B, Purdy JA, Simpson JR, et al. 3-D conformal radiotherapy in head and neck cancer. The Washington University experience. Front Radiat Ther Oncol 1996;29:207-20.
7. Epstein JB, Emerton S, Le ND, et al. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-7.
8. Greer JE, Eltorky M, Robbins KT. A feasibility study of salivary gland autograft transplantation for xerostomia. Head Neck 2000;22:241-6.
9. Grotz KA. Dental care for patients with antineoplastic radiotherapy of the head and neck. Strahlenther Onkol 2003;179:275-8.
10. Grotz KA, Henneicke-von Zepelin HH, Kohnen R, et al. Prospective double-blind study of prophylaxis of radioxerostomia with coumarin/troxerutine in patients with head and neck cancer. Strahlenther Onkol 1999;175:397-403.
11. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 1997;5:281-8.
12. Hazuka MB, Martel MK, Marsh L, et al. Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1993;27:731-7.
13. Huguenin PU, Taussky D, Moe K, et al. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 1999;45:47-52.
14. Janda M, Newman B, Obermair A, et al. Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol 2004;180:78-83.
15. Jensen AB, Hansen O, Jorgensen K, et al. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 1994;33:487-91.
16. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
17. LeVeque FG, Montgomery M, Potter D, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993;11:1124-31.
18. Matzker J, Schreiber J. Synthetic saliva in the treatment of hyposialies, especially in radiation sialadenitis. Z Laryngol Rhinol Otol 1972;51:422-8.
19. Momm F, Guttenberger R. Treatment of xerostomia following radiotherapy - does age matter? Support Care Cancer 2002;10:505-8.
20. Momm F, Müller M, Tsekos A, et al. Xerostomia after radiotherapy: more effective treatment by a mucin-containing spray. HNO 2001;49:831-6.
21. Munter MW, Debus J, Hof H, et al. Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study. Strahlenther Onkol 2002; 178:517-23.
22. Nagler RM, Laufer D. Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration. Int J Radiat Oncol Biol Phys 1998;40:477-81.
23. Nguyen AM. Dental management of patients who receive chemo- and radiation therapy. Gen Dent 1992;40:305-11.
24. Nicholls C, Ilankovan V. An audit of oral and dental health regimens practised in the management of oropharyngeal cancer. Br J Oral Maxillofac Surg 1998;36:63-6.
25. Ramirez-Amador V, Silverman SJ, Mayer P, et al. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:149-53.
26. Rieke JW, Hafermann MD, Johnson JT, et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 1995;31:661-9.
27. Sauer R, Strnad V. New data on cytoprotection in radiotherapy. Strahlenther Onkol 1999;175:Suppl 4:1.
28. Schmidberger H, Rave-Frank M, Kim S, et al. Radiation-induced mucositis and neutrophil granulocytes in oral mucosa. Strahlenther Onkol 2003;179:667-72.
29. Schonekas KG, Wagner W, Prott FJ. Amifostine - a radioprotector in locally advanced head and neck tumors. Strahlenther Onkol 1999;175:Suppl 4:27-9.
30. S'Gravenmade EJ, Roukema PA, Panders AK. The effect of mucin-containing artificial saliva on severe xerostomia. Int J Oral Surg 1974;3:435-9.
31. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:46-50.
32. Vacha P, Fehlauer F, Mahlmann B, et al. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Strahlenther Onkol 2003;179:385-9.
33. Vacha P, Marx M, Engel A, et al. Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial. Strahlenther Onkol 1999;175:Suppl 4:18-22.
34. Van Steenberghe D, Van den Eynde E, Jacobs R, et al. Effect of a lactoperoxidase containing toothpaste in radiation-induced xerostomia. Int Dent J 1994;44:133-8.
35. Warde P, Kroll B, O'Sullivan B, et al. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer 2000;8:203-8.
36. Wiltfang J, Grabenbauer G, Bloch-Birkholz A, et al. Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study - first results. Strahlenther Onkol 2003;179:682-9.
37. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195-205.